RT Journal Article
SR Electronic
T1 Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003255
DO 10.1136/jitc-2021-003255
VO 10
IS 3
A1 Garcia-Carbonero, Rocio
A1 Bazan-Peregrino, Miriam
A1 Gil-Martín, Marta
A1 Álvarez, Rafael
A1 Macarulla, Teresa
A1 Riesco-Martinez, Maria C
A1 Verdaguer, Helena
A1 Guillén-Ponce, Carmen
A1 Farrera-Sal, Martí
A1 Moreno, Rafael
A1 Mato-Berciano, Ana
A1 Maliandi, Maria Victoria
A1 Torres-Manjon, Silvia
A1 Costa, Marcel
A1 del Pozo, Natalia
A1 Martínez de Villarreal, Jaime
A1 Real, Francisco X
A1 Vidal, Noemí
A1 Capella, Gabriel
A1 Alemany, Ramon
A1 Blasi, Emma
A1 Blasco, Carmen
A1 Cascalló, Manel
A1 Salazar, Ramon
YR 2022
UL http://jitc.bmj.com/content/10/3/e003255.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.